Big Gain For Ocugen, Inc.

Fri 24 Jul 20 at 05:33 PM
Big Gain For Ocugen, Inc.

Ocugen, Inc. (OCGN:NASDAQ) jumped higher at $0.38, representing a gain of 32.9%. The stock got featured on our News Catalysts scanner on Tue 21 Jul 20 at 07:49 PM in the 'MISCELLANEOUS' category. From Thu 09 Jul 20, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Tue 21 Jul 20 at $0.5 with a volume of 215M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).